{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:29:50Z","timestamp":1785205790799,"version":"3.55.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"F\u00f6FoLe","award":["852"],"award-info":[{"award-number":["852"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0158299","type":"journal-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T13:34:54Z","timestamp":1470663294000},"page":"e0158299","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) as a Biomarker in the Mouse Model of Experimental Autoimmune Myocarditis (EAM)"],"prefix":"10.1371","volume":"11","author":[{"given":"U.","family":"Grabmaier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Grabmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. C.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Lackermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Herbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Todica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. T.","family":"Weckbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,8]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2011.09.074","article-title":"Update on myocarditis","volume":"59","author":"I Kindermann","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"issue":"21","key":"ref2","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/eurheartj\/ehr165","article-title":"The management of myocarditis","volume":"32","author":"HP Schultheiss","year":"2011","journal-title":"European heart journal"},{"issue":"Suppl O","key":"ref3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/eurheartj\/16.suppl_O.173","article-title":"The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID)","volume":"16","author":"B Maisch","year":"1995","journal-title":"Eur Heart J"},{"issue":"33","key":"ref4","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"AL Caforio","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10001","article-title":"Inhibition of LFA-1\/ICAM-1 and VLA-4\/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases","volume":"22","author":"H Yusuf-Makagiansar","year":"2002","journal-title":"Med Res Rev"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/art.1780360412","article-title":"Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1","volume":"36","author":"JC Mason","year":"1993","journal-title":"Arthritis and rheumatism"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13075-015-0896-7","article-title":"Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1","volume":"18","author":"MJ Lewis","year":"2016","journal-title":"Arthritis research & therapy"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2249.1994.tb06107.x","article-title":"Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study","volume":"97","author":"PE Spronk","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/hc3701.095949","article-title":"Circulating cell adhesion molecules and death in patients with coronary artery disease","volume":"104","author":"S Blankenberg","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00395-013-0388-3","article-title":"Enhanced stem cell migration mediated by VCAM-1\/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy","volume":"108","author":"S Brunner","year":"2013","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/CIRCRESAHA.109.196287","article-title":"Heart-infiltrating prominin-1+\/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis","volume":"105","author":"G Kania","year":"2009","journal-title":"Circulation research"},{"issue":"23","key":"ref12","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1161\/CIRCULATIONAHA.112.000434","article-title":"Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis","volume":"127","author":"G Kania","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ehjci\/jev237","article-title":"FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction","volume":"17","author":"L Gross","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"14","key":"ref14","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/CIRCULATIONAHA.110.952820","article-title":"CD69 limits the severity of cardiomyopathy after autoimmune myocarditis","volume":"122","author":"A Cruz-Adalia","year":"2010","journal-title":"Circulation"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1084\/jem.20132126","article-title":"Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy","volume":"211","author":"L Wu","year":"2014","journal-title":"The Journal of experimental medicine"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/eurheartj\/ehq498","article-title":"Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control","volume":"32","author":"P Bobbert","year":"2011","journal-title":"European heart journal"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.pcad.2009.11.006","article-title":"Myocarditis","volume":"52","author":"LA Blauwet","year":"2010","journal-title":"Progress in cardiovascular diseases"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.CIR.0000043802.38699.66","article-title":"Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3","volume":"107","author":"U Eriksson","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.109.213157","article-title":"Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy","volume":"106","author":"GC Baldeviano","year":"2010","journal-title":"Circulation research"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.4049\/jimmunol.167.9.5464","article-title":"Dual role of the IL-12\/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma","volume":"167","author":"U Eriksson","year":"2001","journal-title":"Journal of immunology"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/nm960","article-title":"Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity","volume":"9","author":"U Eriksson","year":"2003","journal-title":"Nature medicine"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/cvr\/cvr148","article-title":"IL-6-mediated Th17 differentiation through RORgammat is essential for the initiation of experimental autoimmune myocarditis","volume":"91","author":"T Yamashita","year":"2011","journal-title":"Cardiovascular research"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"e94615","DOI":"10.1371\/journal.pone.0094615","article-title":"The role of 1.5 tesla MRI and anesthetic regimen concerning cardiac analysis in mice with cardiomyopathy","volume":"9","author":"U Grabmaier","year":"2014","journal-title":"PloS one"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0158299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:01:24Z","timestamp":1540335684000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0158299"}},"subtitle":[],"editor":[{"given":"Christoph E","family":"Hagemeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,8]]},"references-count":23,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0158299","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,8]]}}}